| 1 | West syndrome | Enrichment | CSNK1E, GNAO1, GRIA3, GRIN1, GRIN2B, KCNQ2, NTRK2, SCN1A, SCN2A, SCN8A, SLC25A12, STXBP1 | 9.25 |
| 2 | Autosomal dominant non-syndromic intellectual disability | Enrichment | BRSK2, CACNG2, CAMK2A, CAMK2B, DPYSL2, GABBR1, GRIA1, GRIN1, GRIN2B, KCNQ2, SCN8A | 7.47 |
| 3 | Early-onset parkinson's disease | Enrichment | LRRK2, PARK7, PINK1, PRKN, SNCA, UCHL1 | 6.71 |
| 4 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | NGF, NTRK1, SCN10A, SCN11A, SCN9A | 6.71 |
| 5 | Early-onset autosomal dominant alzheimer disease | Enrichment | APP, PSEN1, PSEN2, SORL1, TREM2 | 6.71 |
| 6 | Developmental and epileptic encephalopathy 1 | Enrichment | CSNK1E, GNAO1, GRIN1, KCNQ2, SCN1A, SCN8A, SLC25A12 | 5.71 |
| 7 | Developmental and epileptic encephalopathy | Enrichment | GNAO1, GRIA3, KCNQ2, SCN1A, SCN2A, SCN8A, SNAP25, STXBP1 | 5.62 |
| 8 | Epilepsy | Enrichment | BSN, GRIN2A, GRIN2B, MECP2, SCN1A, SCN2A, SCN8A, SYN1 | 5.25 |
| 9 | Benign epilepsy with centrotemporal spikes | Enrichment | CNTNAP2, GRIN1, GRIN2A, RBFOX3, SCN1A, SCN1B, SCN2A, SCN9A | 5.17 |
| 10 | Centralopathic epilepsy | Enrichment | CNTNAP2, GRIN1, GRIN2A, RBFOX3, SCN1A, SCN1B, SCN2A, SCN9A | 5.01 |
| 11 | Focal epilepsy | Enrichment | MECP2, SCN2A, SCN8A, SNAP25 | 4.89 |
| 12 | Complex neurodevelopmental disorder | Enrichment | CLCN3, CNTN2, DLG4, DYRK1A, GRIA4, GRIN2B, HTT, PLXNA1, SCN2A, SCN8A, SHANK2, SYNGAP1, TBR1 | 4.85 |
| 13 | Alzheimer disease 4 | Enrichment | APOE, PSEN1, PSEN2 | 4.80 |
| 14 | Hereditary sodium channelopathy-related small fibers neuropathy | Enrichment | SCN10A, SCN11A, SCN9A | 4.80 |
| 15 | Autism spectrum disorder | Enrichment | CNTNAP2, DYRK1A, GRIA1, GRIN2B, MARK2, MECP2, NF1, PRKN, SCN2A, SHANK2, SHANK3, STXBP1 | 4.73 |
| 16 | Developmental and epileptic encephalopathy 14 | Enrichment | KCNQ2, SCN1A, SCN2A, SLC12A5 | 4.35 |
| 17 | Erythermalgia, primary | Enrichment | SCN10A, SCN11A, SCN9A | 4.21 |
| 18 | Early infantile developmental and epileptic encephalopathy | Enrichment | CASK, GNAO1, GRIN1, SCN1B, SCN2A | 4.20 |
| 19 | Dravet syndrome | Enrichment | SCN1A, SCN1B, SCN2A, SCN9A | 4.14 |
| 20 | Autism | Enrichment | CAMK2G, CNTNAP2, MECP2, PRKN, SCN1A, SCN2A, SCN8A, STX1A, STXBP1 | 4.12 |
| 21 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | DCTN1, MAPT, NEFH, OPTN, PSEN1, SOD1, TARDBP, TREM2 | 4.03 |
| 22 | Frontotemporal dementia 1 | Enrichment | DCTN1, MAPT, PSEN1, TREM2 | 3.95 |
| 23 | Paroxysmal extreme pain disorder | Enrichment | SCN10A, SCN11A, SCN9A | 3.82 |
| 24 | Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia | Enrichment | OPTN, SOD1, TARDBP | 3.82 |
| 25 | Self-limited infantile epilepsy | Enrichment | KCNQ2, SCN2A, SCN8A | 3.82 |
| 26 | Dystonia | Enrichment | CAMK2B, CASK, GRIA3, MECP2, TH, TOR1A | 3.67 |
| 27 | Alzheimer's disease | Enrichment | APOE, APP, MAPT, PSEN1 | 3.63 |
| 28 | Microcephaly | Enrichment | CAMK2B, CASK, DYRK1A, GNAO1, GRIN2B, MECP2, PPFIBP1, SCN1A, SNAP25, STXBP1, SYNGAP1 | 3.57 |
| 29 | Generalized epilepsy with febrile seizures plus | Enrichment | SCN1A, SCN1B, SCN2A, SCN9A | 3.49 |
| 30 | Semantic dementia | Enrichment | MAPT, PSEN1, TREM2 | 3.29 |
| 31 | Motor neuron disease | Enrichment | OPTN, SOD1, TARDBP | 3.29 |
| 32 | Cerebral amyloid angiopathy, cst3-related | Enrichment | APP, CST3 | 3.20 |
| 33 | Alzheimer disease 3 | Enrichment | APOE, PSEN1 | 3.20 |
| 34 | Seizures, benign familial infantile, 3 | Enrichment | KCNQ2, SCN2A | 3.20 |
| 35 | Pick disease of brain | Enrichment | MAPT, PSEN1 | 3.20 |
| 36 | Parkinson disease 15, autosomal recessive early-onset | Enrichment | FBXO7, SNCA | 3.20 |
| 37 | Phakomatosis cesioflammea | Enrichment | GNA11, GNAQ | 3.20 |
| 38 | Alzheimer disease, familial, 1 | Enrichment | APOE, APP, MAPT, PSEN1 | 3.14 |
| 39 | Progressive non-fluent aphasia | Enrichment | MAPT, PSEN1, TREM2 | 2.93 |
| 40 | Behavioral variant of frontotemporal dementia | Enrichment | MAPT, PSEN1, TREM2 | 2.93 |
| 41 | Body mass index quantitative trait locus 11 | Enrichment | CARTPT, CAST, GRIA4, PCSK1, POMC, SCN1A | 2.82 |
| 42 | Amyotrophic lateral sclerosis 1 | Enrichment | DCTN1, NEFH, SOD1 | 2.78 |
| 43 | Lissencephaly | Enrichment | DCX, PAFAH1B1, TUBB, TUBB3 | 2.78 |
| 44 | Thyroid carcinoma, familial medullary | Enrichment | NTRK1, RET | 2.73 |
| 45 | Band heterotopia | Enrichment | DCX, PAFAH1B1 | 2.73 |
| 46 | Body mass index quantitative trait locus 12 | Enrichment | CAST, PCSK1 | 2.73 |
| 47 | Generalized epilepsy with febrile seizures plus, type 1 | Enrichment | SCN1A, SCN1B | 2.73 |
| 48 | Proprotein convertase 1/3 deficiency | Enrichment | CAST, PCSK1 | 2.73 |
| 49 | Anastomosing haemangioma | Enrichment | GNA11, GNAQ | 2.73 |
| 50 | Keratoacanthoma | Enrichment | NOTCH1, NOTCH2 | 2.73 |
| 51 | Spastic ataxia | Enrichment | DAB1, ITPR1, SCN2A, STXBP1, TUBB3, WFS1 | 2.69 |
| 52 | Undetermined early-onset epileptic encephalopathy | Enrichment | GABBR2, NTRK2, SCN1A, SCN1B, SCN8A, SLC1A2 | 2.57 |
| 53 | Parkinson disease, late-onset | Enrichment | LRRK2, MAPT, PRKN, SNCA | 2.55 |
| 54 | Hereditary progressive cardiac conduction defect | Enrichment | SCN1B, SCN5A | 2.44 |
| 55 | Sick sinus syndrome | Enrichment | MECP2, SCN5A | 2.44 |
| 56 | Complex hereditary spastic paraplegia | Enrichment | PRKN, SORL1 | 2.44 |
| 57 | Stereotypic movement disorder | Enrichment | MECP2, SNAP25, SYNGAP1 | 2.43 |
| 58 | Brugada syndrome | Enrichment | SCN10A, SCN1B, SCN2B, SCN5A | 2.42 |
| 59 | Differentiated thyroid carcinoma | Enrichment | NKX2-1, NTRK1, NTRK3, RET | 2.25 |
| 60 | Capillary malformations, congenital | Enrichment | GNA11, GNAQ | 2.22 |
| 61 | Dementia, lewy body | Enrichment | SNCA, SNCB | 2.22 |
| 62 | Dementia | Enrichment | MAPT, PSEN1 | 2.22 |
| 63 | Melanoma, uveal | Enrichment | GNA11, GNAQ | 2.05 |
| 64 | Parkinson disease 6, autosomal recessive early-onset | Enrichment | PARK7, PINK1 | 2.05 |
| 65 | Brugada syndrome 1 | Enrichment | SCN10A, SCN5A | 1.91 |
| 66 | Rett syndrome | Enrichment | GABBR2, MECP2 | 1.91 |
| 67 | Non-syndromic x-linked intellectual disability | Enrichment | CASK, DLG3, MECP2, SYP | 1.91 |
| 68 | Fetal akinesia deformation sequence 1 | Enrichment | CNTNAP1, SCN4A, SCN5A, SCN8A | 1.87 |
| 69 | Hereditary paraganglioma-pheochromocytoma syndromes | Enrichment | DLST, NF1, RET | 1.82 |
| 70 | Rett syndrome, congenital variant | Enrichment | GABBR2, MECP2 | 1.80 |
| 71 | Alternating hemiplegia of childhood | Enrichment | SCN2A, SLC1A3 | 1.80 |
| 72 | Choreatic disease | Enrichment | GNAO1, NKX2-1 | 1.80 |
| 73 | Congenital nervous system abnormality | Enrichment | CAMK2B, CASK, DCX, GNAO1, MECP2, OPHN1, PSEN1 | 1.76 |
| 74 | Nervous system disease | Enrichment | CAMK2B, CASK, DCX, GNAO1, MECP2, OPHN1, PSEN1 | 1.76 |
| 75 | Congenital stationary night blindness | Enrichment | GNB3, RHO, SAG | 1.72 |
| 76 | Neurofibromatosis, type i | Enrichment | GABBR1, NF1 | 1.70 |
| 77 | Myoclonic-atonic epilepsy | Enrichment | SCN1A, SYNGAP1 | 1.70 |
| 78 | Autosomal dominant cerebellar ataxia | Enrichment | DAGLA, LRRK2 | 1.70 |
| 79 | Distal arthrogryposis | Enrichment | CNTNAP1, SCN4A, SCN5A, SCN8A | 1.68 |
| 80 | Familial atrial fibrillation | Enrichment | SCN1B, SCN2B, SCN5A | 1.67 |
| 81 | Nephrolithiasis | Enrichment | NHERF1, SLC12A1 | 1.61 |
| 82 | Multiple endocrine neoplasia, type iib | Enrichment | RET | 1.60 |
| 83 | Precocious puberty, central, 1 | Enrichment | KISS1R | 1.60 |
| 84 | Keratolytic winter erythema | Enrichment | CTSB | 1.60 |
| 85 | Cataract 41 | Enrichment | WFS1 | 1.60 |
| 86 | Diabetes insipidus, neurohypophyseal | Enrichment | AVP | 1.60 |
| 87 | Hypocalciuric hypercalcemia, familial, type ii | Enrichment | GNA11 | 1.60 |
| 88 | Pyloric stenosis, infantile hypertrophic, 1 | Enrichment | NOS1 | 1.60 |
| 89 | Skin creases, congenital symmetric circumferential, 1 | Enrichment | TUBB | 1.60 |
| 90 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 1.60 |
| 91 | Perry syndrome | Enrichment | DCTN1 | 1.60 |
| 92 | Parkinson disease 1, autosomal dominant | Enrichment | SNCA | 1.60 |
| 93 | Atrophoderma vermiculata | Enrichment | LRP1 | 1.60 |
| 94 | Calcification of joints and arteries | Enrichment | NT5E | 1.60 |
| 95 | Hydrocephalus due to congenital stenosis of aqueduct of sylvius | Enrichment | L1CAM | 1.60 |
| 96 | Epilepsy, focal, with speech disorder and with or without impaired intellectual development | Enrichment | GRIN2A | 1.60 |
| 97 | Sea-blue histiocyte disease | Enrichment | APOE | 1.60 |
| 98 | Wolfram syndrome 1 | Enrichment | WFS1 | 1.60 |
| 99 | Dicarboxylic aminoaciduria | Enrichment | SLC1A1 | 1.60 |
| 100 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement | Enrichment | TUBB3 | 1.60 |
| 101 | Deafness, autosomal dominant 6 | Enrichment | WFS1 | 1.60 |
| 102 | Fatal familial insomnia | Enrichment | PRNP | 1.60 |
| 103 | Systemic lupus erythematosus 6 | Enrichment | ITGAM | 1.60 |
| 104 | Nephrolithiasis/osteoporosis, hypophosphatemic, 2 | Enrichment | NHERF1 | 1.60 |
| 105 | Night blindness, congenital stationary, autosomal dominant 1 | Enrichment | RHO | 1.60 |
| 106 | Blood group, diego system | Enrichment | SLC4A1 | 1.60 |
| 107 | Dystonia 1, torsion, autosomal dominant | Enrichment | TOR1A | 1.60 |
| 108 | Facial hypertrichosis | Enrichment | MECP2 | 1.60 |
| 109 | Macular degeneration, age-related, 11 | Enrichment | CST3 | 1.60 |
| 110 | Carney complex, type 1 | Enrichment | PRKAR1A | 1.60 |
| 111 | Ovalocytosis, southeast asian | Enrichment | SLC4A1 | 1.60 |
| 112 | Char syndrome | Enrichment | TFAP2B | 1.60 |
| 113 | Resting heart rate, variation in | Enrichment | ADRB1 | 1.60 |
| 114 | Brugada syndrome 5 | Enrichment | SCN1B | 1.60 |
| 115 | Developmental and epileptic encephalopathy 39 with leukodystrophy | Enrichment | SLC25A12 | 1.60 |
| 116 | Schwannomatosis, vestibular | Enrichment | NF2 | 1.60 |
| 117 | Hajdu-cheney syndrome | Enrichment | NOTCH2 | 1.60 |
| 118 | Alagille syndrome 2 | Enrichment | NOTCH2 | 1.60 |
| 119 | Autism 15 | Enrichment | CNTNAP2 | 1.60 |
| 120 | Blood group--wright antigen | Enrichment | SLC4A1 | 1.60 |
| 121 | Spherocytosis, type 4 | Enrichment | SLC4A1 | 1.60 |
| 122 | Episodic ataxia, type 6 | Enrichment | SLC1A3 | 1.60 |
| 123 | Maturity-onset diabetes of the young, type 6 | Enrichment | NEUROD1 | 1.60 |
| 124 | Acne inversa, familial, 1 | Enrichment | NCSTN | 1.60 |
| 125 | Lipoprotein glomerulopathy | Enrichment | APOE | 1.60 |
| 126 | Gerstmann-straussler disease | Enrichment | PRNP | 1.60 |
| 127 | Lateral meningocele syndrome | Enrichment | NOTCH3 | 1.60 |
| 128 | Focal segmental glomerulosclerosis 2 | Enrichment | TRPC6 | 1.60 |
| 129 | Keratosis pilaris atrophicans | Enrichment | LRP1 | 1.60 |
| 130 | Episodic pain syndrome, familial, 3 | Enrichment | SCN11A | 1.60 |
| 131 | Parkinson disease 4, autosomal dominant | Enrichment | SNCA | 1.60 |
| 132 | Cortical dysplasia, complex, with other brain malformations 6 | Enrichment | TUBB | 1.60 |
| 133 | Hypogonadotropic hypogonadism 8 with or without anosmia | Enrichment | KISS1R | 1.60 |
| 134 | Developmental and epileptic encephalopathy 7 | Enrichment | KCNQ2 | 1.60 |
| 135 | Developmental and epileptic encephalopathy 11 | Enrichment | SCN2A | 1.60 |
| 136 | Leprosy 2 | Enrichment | PRKN | 1.60 |
| 137 | Charcot-marie-tooth disease, demyelinating, type 1f | Enrichment | NEFL | 1.60 |
| 138 | Advanced sleep phase syndrome, familial, 2 | Enrichment | CSNK1D | 1.60 |
| 139 | Autism 17 | Enrichment | SHANK2 | 1.60 |
| 140 | Wolfram-like syndrome, autosomal dominant | Enrichment | WFS1 | 1.60 |
| 141 | Kuru | Enrichment | PRNP | 1.60 |
| 142 | Neuropathy, hereditary sensory and autonomic, type vii | Enrichment | SCN11A | 1.60 |
| 143 | Epilepsy, idiopathic generalized 14 | Enrichment | SLC12A5 | 1.60 |
| 144 | Deafness, autosomal dominant 56 | Enrichment | TNC | 1.60 |
| 145 | Neurodevelopmental disorder with involuntary movements | Enrichment | GNAO1 | 1.60 |
| 146 | Intellectual developmental disorder, autosomal dominant 7 | Enrichment | DYRK1A | 1.60 |
| 147 | Developmental and epileptic encephalopathy 41 | Enrichment | SLC1A2 | 1.60 |
| 148 | Whim syndrome 1 | Enrichment | CXCR4 | 1.60 |
| 149 | Developmental and epileptic encephalopathy 27 | Enrichment | GRIN2B | 1.60 |
| 150 | Lissencephaly 7 with cerebellar hypoplasia | Enrichment | CDK5 | 1.60 |
| 151 | Spinocerebellar ataxia 41 | Enrichment | TRPC3 | 1.60 |
| 152 | Neuroocular syndrome 2, paroxysmal type | Enrichment | DAGLA | 1.60 |
| 153 | Cryohydrocytosis | Enrichment | SLC4A1 | 1.60 |
| 154 | Sturge-weber syndrome | Enrichment | GNAQ | 1.60 |
| 155 | Spinocerebellar ataxia, autosomal recessive 13 | Enrichment | GRM1 | 1.60 |
| 156 | Schizophrenia 18 | Enrichment | SLC1A1 | 1.60 |
| 157 | Atrial fibrillation, familial, 14 | Enrichment | SCN2B | 1.60 |
| 158 | Blood group--swann system | Enrichment | SLC4A1 | 1.60 |
| 159 | Charcot-marie-tooth disease, axonal, type 2cc | Enrichment | NEFH | 1.60 |
| 160 | Neurodevelopmental disorder with seizures and brain abnormalities | Enrichment | CLCN3 | 1.60 |
| 161 | Epilepsy, idiopathic generalized 17 | Enrichment | HCN2 | 1.60 |
| 162 | Spastic paraplegia 78, autosomal recessive | Enrichment | ATP13A2 | 1.60 |
| 163 | Intellectual developmental disorder, x-linked 50 | Enrichment | SYN1 | 1.60 |
| 164 | Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities | Enrichment | PPFIBP1 | 1.60 |
| 165 | Intellectual developmental disorder, x-linked, syndromic, lubs type | Enrichment | MECP2 | 1.60 |
| 166 | Developmental and epileptic encephalopathy 117 | Enrichment | SNAP25 | 1.60 |
| 167 | Intellectual developmental disorder, x-linked, syndromic, billuart type | Enrichment | OPHN1 | 1.60 |
| 168 | Developmental and epileptic encephalopathy 58 | Enrichment | NTRK2 | 1.60 |
| 169 | Developmental and epileptic encephalopathy 63 | Enrichment | CPLX1 | 1.60 |
| 170 | Corpus callosum, partial agenesis of, x-linked | Enrichment | L1CAM | 1.60 |
| 171 | Hydrocephalus, congenital, x-linked | Enrichment | L1CAM | 1.60 |
| 172 | Intellectual developmental disorder, autosomal recessive 63 | Enrichment | CAMK2A | 1.60 |
| 173 | Oocyte/zygote/embryo maturation arrest 14 | Enrichment | CDC20 | 1.60 |
| 174 | Autism x-linked 3 | Enrichment | MECP2 | 1.60 |
| 175 | Intellectual developmental disorder, autosomal dominant 54 | Enrichment | CAMK2B | 1.60 |
| 176 | Charcot-marie-tooth disease, dominant intermediate g | Enrichment | NEFL | 1.60 |
| 177 | Neurodevelopmental disorder with poor language and loss of hand skills | Enrichment | GABBR2 | 1.60 |
| 178 | Developmental and epileptic encephalopathy 59 | Enrichment | GABBR2 | 1.60 |
| 179 | Moyamoya disease 7 | Enrichment | ANO1 | 1.60 |
| 180 | Myoclonus, familial, 2 | Enrichment | SCN8A | 1.60 |
| 181 | Baker-gordon syndrome | Enrichment | SYT1 | 1.60 |
| 182 | Intellectual developmental disorder, x-linked, syndromic, wu type | Enrichment | GRIA3 | 1.60 |
| 183 | Lissencephaly, x-linked, 1 | Enrichment | DCX | 1.60 |
| 184 | Delpire-mcneill syndrome | Enrichment | SLC12A2 | 1.60 |
| 185 | Leukodystrophy, hypomyelinating, 20 | Enrichment | CNP | 1.60 |
| 186 | Developmental and epileptic encephalopathy 89 | Enrichment | GAD1 | 1.60 |
| 187 | Retinitis pigmentosa 47 | Enrichment | SAG | 1.60 |
| 188 | Spongiform encephalopathy with neuropsychiatric features | Enrichment | PRNP | 1.60 |
| 189 | Oguchi disease 1 | Enrichment | SAG | 1.60 |
| 190 | Parkinson-dementia syndrome | Enrichment | MAPT | 1.60 |
| 191 | Epilepsy, x-linked 1, with variable learning disabilities and behavior disorders | Enrichment | SYN1 | 1.60 |
| 192 | Pheochromocytoma/paraganglioma syndrome 7 | Enrichment | DLST | 1.60 |
| 193 | Intellectual developmental disorder, autosomal dominant 76 | Enrichment | MARK2 | 1.60 |
| 194 | Masa syndrome | Enrichment | L1CAM | 1.60 |
| 195 | Atrial fibrillation, familial, 13 | Enrichment | SCN1B | 1.60 |
| 196 | Supranuclear palsy, progressive, 1 | Enrichment | MAPT | 1.60 |
| 197 | Cataract 49 | Enrichment | PANK4 | 1.60 |
| 198 | Familial febrile seizures 2 | Enrichment | HCN2 | 1.60 |
| 199 | Central diabetes insipidus | Enrichment | AVP | 1.60 |
| 200 | Huntington disease-like 1 | Enrichment | PRNP | 1.60 |
| 201 | Myxoma, intracardiac | Enrichment | PRKAR1A | 1.60 |
| 202 | Cardiomyopathy, dilated, 1v | Enrichment | PSEN2 | 1.60 |
| 203 | Developmental and epileptic encephalopathy 17 | Enrichment | GNAO1 | 1.60 |
| 204 | Prostate cancer/brain cancer susceptibility | Enrichment | EPHB2 | 1.60 |
| 205 | Intestinal dysmotility syndrome | Enrichment | ANO1 | 1.60 |
| 206 | Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination | Enrichment | NACC1 | 1.60 |
| 207 | Hyperinsulinemic hypoglycemia, familial, 6 | Enrichment | GLUD1 | 1.60 |
| 208 | Progressive supranuclear palsy | Enrichment | MAPT | 1.60 |
| 209 | Lethal congenital contracture syndrome 7 | Enrichment | CNTNAP1 | 1.60 |
| 210 | Motor peripheral neuropathy | Enrichment | AGTPBP1 | 1.60 |
| 211 | Hypercholesterolemia, familial, 3 | Enrichment | PCSK9 | 1.60 |
| 212 | Coronary artery disease, autosomal dominant, 1 | Enrichment | MEF2A | 1.60 |
| 213 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | Enrichment | GRIN1 | 1.60 |
| 214 | Cerebral amyloid angiopathy, app-related | Enrichment | APP | 1.60 |
| 215 | X-linked epilepsy with variable learning disabilities and behavior disorders | Enrichment | SYN1 | 1.60 |
| 216 | Kufor-rakeb syndrome | Enrichment | ATP13A2 | 1.60 |
| 217 | Neuronopathy, distal hereditary motor, autosomal dominant 14 | Enrichment | DCTN1 | 1.60 |
| 218 | Parkinson disease 7, autosomal recessive early-onset | Enrichment | PARK7 | 1.60 |
| 219 | Episodic ataxia, type 9 | Enrichment | SCN2A | 1.60 |
| 220 | Agammaglobulinemia 5, autosomal dominant | Enrichment | LRRC8A | 1.60 |
| 221 | Cardiomyopathy, dilated, 1u | Enrichment | PSEN1 | 1.60 |
| 222 | Intellectual developmental disorder, autosomal dominant 6, with or without seizures | Enrichment | GRIN2B | 1.60 |
| 223 | Charcot-marie-tooth disease type 1f | Enrichment | NEFL | 1.60 |
| 224 | Periodic fever, menstrual cycle-dependent | Enrichment | HTR1A | 1.60 |
| 225 | Olmsted syndrome 1 | Enrichment | TRPV3 | 1.60 |
| 226 | Hermansky-pudlak syndrome 7 | Enrichment | DTNBP1 | 1.60 |
| 227 | Intellectual developmental disorder, autosomal dominant 10 | Enrichment | CACNG2 | 1.60 |
| 228 | Episodic pain syndrome, familial, 2 | Enrichment | SCN10A | 1.60 |
| 229 | Familial alzheimer-like prion disease | Enrichment | PRNP | 1.60 |
| 230 | Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements | Enrichment | VAMP2 | 1.60 |
| 231 | Alzheimer disease 17 | Enrichment | TREM2 | 1.60 |
| 232 | Hypocalcemia, autosomal dominant 2 | Enrichment | GNA11 | 1.60 |
| 233 | Neurodevelopmental disorder with language impairment and behavioral abnormalities | Enrichment | GRIA2 | 1.60 |
| 234 | Myofibromatosis, infantile, 2 | Enrichment | NOTCH3 | 1.60 |
| 235 | Deafness, autosomal dominant 78 | Enrichment | SLC12A2 | 1.60 |
| 236 | Spinocerebellar ataxia 37 | Enrichment | DAB1 | 1.60 |
| 237 | Benign familial infantile epilepsy | Enrichment | SCN2A | 1.60 |
| 238 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 1.60 |
| 239 | Epilepsy with generalized tonic-clonic seizures | Enrichment | SNAP25 | 1.60 |
| 240 | Syndromic x-linked intellectual disability lubs type | Enrichment | MECP2 | 1.60 |
| 241 | Retinitis pigmentosa 4 | Enrichment | RHO | 1.60 |
| 242 | Acne inversa, familial, 2, with or without dowling-degos disease | Enrichment | PSENEN | 1.60 |
| 243 | Developmental and epileptic encephalopathy 101 | Enrichment | GRIN1 | 1.60 |
| 244 | Obesity, hyperphagia, and developmental delay | Enrichment | NTRK2 | 1.60 |
| 245 | Parkinson disease 5, autosomal dominant | Enrichment | UCHL1 | 1.60 |
| 246 | Acne inversa, familial, 3 | Enrichment | PSEN1 | 1.60 |
| 247 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant | Enrichment | GRIN1 | 1.60 |
| 248 | Schizophrenia 15 | Enrichment | SHANK3 | 1.60 |
| 249 | Neurodevelopmental disorder with or without seizures and gait abnormalities | Enrichment | GRIA4 | 1.60 |
| 250 | Patent ductus arteriosus 2 | Enrichment | TFAP2B | 1.60 |
| 251 | Prion disease | Enrichment | PRNP | 1.60 |
| 252 | Intellectual developmental disorder, autosomal recessive 64 | Enrichment | LINGO1 | 1.60 |
| 253 | Kilquist syndrome | Enrichment | SLC12A2 | 1.60 |
| 254 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 1.60 |
| 255 | Lopes-maciel-rodan syndrome | Enrichment | HTT | 1.60 |
| 256 | Bleeding disorder, platelet-type, 22 | Enrichment | EPHB2 | 1.60 |
| 257 | Palmoplantar keratoderma, nonepidermolytic, focal 2 | Enrichment | TRPV3 | 1.60 |
| 258 | Spastic paraplegia 75, autosomal recessive | Enrichment | MAG | 1.60 |
| 259 | Intellectual developmental disorder, autosomal dominant 67 | Enrichment | GRIA1 | 1.60 |
| 260 | Spinocerebellar ataxia 44 | Enrichment | GRM1 | 1.60 |
| 261 | Neuropathy, congenital hypomyelinating, 3 | Enrichment | CNTNAP1 | 1.60 |
| 262 | Congenital myopathy 9b, proximal, with minicore lesions | Enrichment | FXR1 | 1.60 |
| 263 | Short sleep, familial natural, 2 | Enrichment | ADRB1 | 1.60 |
| 264 | Classic progressive supranuclear palsy syndrome | Enrichment | MAPT | 1.60 |
| 265 | Retinitis pigmentosa 96 | Enrichment | SAG | 1.60 |
| 266 | Autoinflammation with episodic fever and lymphadenopathy | Enrichment | RIPK1 | 1.60 |
| 267 | Arthrogryposis multiplex congenita 5 | Enrichment | TOR1A | 1.60 |
| 268 | Congenital myopathy 9a | Enrichment | FXR1 | 1.60 |
| 269 | Intellectual developmental disorder, autosomal dominant 53 | Enrichment | CAMK2A | 1.60 |
| 270 | Muscular channelopathy | Enrichment | SCN4A | 1.60 |
| 271 | Intellectual developmental disorder, autosomal recessive 76 | Enrichment | GRIA1 | 1.60 |
| 272 | Developmental and epileptic encephalopathy 39 | Enrichment | SLC25A12 | 1.60 |
| 273 | Neurodevelopmental disorder with hypotonia and brain abnormalities | Enrichment | CLCN3 | 1.60 |
| 274 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 | Enrichment | TREM2 | 1.60 |
| 275 | Neurodevelopmental disorder with central and peripheral motor dysfunction | Enrichment | NFASC | 1.60 |
| 276 | Neurodevelopmental disorder with language delay and variable cognitive abnormalities | Enrichment | GABBR1 | 1.60 |
| 277 | Intellectual developmental disorder, autosomal dominant 59 | Enrichment | CAMK2G | 1.60 |
| 278 | Plexiform neurofibroma | Enrichment | NF1 | 1.60 |
| 279 | Dworschak-punetha neurodevelopmental syndrome | Enrichment | PLXNA1 | 1.60 |
| 280 | Narcolepsy | Enrichment | HCRT | 1.60 |
| 281 | Neurofibroma | Enrichment | NF1 | 1.60 |
| 282 | Developmental and epileptic encephalopathy 113 | Enrichment | SV2A | 1.60 |
| 283 | Dcx-related disorders | Enrichment | DCX | 1.60 |
| 284 | Atypical progressive supranuclear palsy syndrome | Enrichment | MAPT | 1.60 |
| 285 | Syndromic x-linked intellectual disability 94 | Enrichment | GRIA3 | 1.60 |
| 286 | Hot water epilepsy | Enrichment | SLC1A1 | 1.60 |
| 287 | Leukodystrophy, adult-onset, autosomal dominant, without amyloid angiopathy | Enrichment | CST3 | 1.60 |
| 288 | Charcot-marie-tooth disease type 2b5 | Enrichment | NEFL | 1.60 |
| 289 | Neurofibromatosis | Enrichment | NF1 | 1.60 |
| 290 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 1.60 |
| 291 | Catechol-o-methyltransferase activity, variation in | Enrichment | COMT | 1.60 |
| 292 | Grin2b-related neurodevelopmental disorder | Enrichment | GRIN2B | 1.60 |
| 293 | Wolfram-like syndrome | Enrichment | WFS1 | 1.60 |
| 294 | Transient cerebral ischemia | Enrichment | NOTCH3 | 1.60 |
| 295 | Landau-kleffner syndrome | Enrichment | GRIN2A | 1.60 |
| 296 | Chromosome 17q11.2 deletion syndrome | Enrichment | NF1 | 1.60 |
| 297 | Rare disease with autism | Enrichment | SHANK2 | 1.60 |
| 298 | Cask-related intellectual disability | Enrichment | CASK | 1.60 |
| 299 | Thyroid cancer | Enrichment | RET | 1.60 |
| 300 | Optic nerve glioma | Enrichment | NF1 | 1.60 |
| 301 | Mutism | Enrichment | SHANK3 | 1.60 |
| 302 | Prp systemic amyloidosis | Enrichment | PRNP | 1.60 |
| 303 | Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 | Enrichment | NOTCH3 | 1.60 |
| 304 | Xq27.3q28 duplication syndrome | Enrichment | FMR1 | 1.60 |
| 305 | Acoustic neuroma | Enrichment | NF2 | 1.60 |
| 306 | Dyt1 early-onset isolated dystonia | Enrichment | TOR1A | 1.60 |
| 307 | X-linked complicated spastic paraplegia type 1 | Enrichment | L1CAM | 1.60 |
| 308 | Inherited human prion disease | Enrichment | PRNP | 1.60 |
| 309 | Intellectual disability, autosomal dominant 8 | Enrichment | GRIN1 | 1.60 |
| 310 | Juvenile huntington disease | Enrichment | HTT | 1.60 |
| 311 | Gria2-related neurodevelopmental disorder | Enrichment | GRIA2 | 1.60 |
| 312 | Early-onset epileptic encephalopathy and intellectual disability due to grin2a mutation | Enrichment | GRIN2A | 1.60 |
| 313 | Grin2a-related disorders | Enrichment | GRIN2A | 1.60 |
| 314 | Pitt-hopkins-like syndrome | Enrichment | CNTNAP2 | 1.60 |
| 315 | Lissencephaly due to lis1 mutation | Enrichment | PAFAH1B1 | 1.60 |
| 316 | Gnao1-related disorder | Enrichment | GNAO1 | 1.60 |
| 317 | Kcnq2-related disorders | Enrichment | KCNQ2 | 1.60 |
| 318 | Pash syndrome | Enrichment | NCSTN | 1.60 |
| 319 | Huntington's disease-like | Enrichment | PSEN2 | 1.60 |
| 320 | Phakomatosis cesiomarmorata | Enrichment | GNA11 | 1.60 |
| 321 | Chondromyxoid fibroma | Enrichment | GRM1 | 1.60 |
| 322 | Tardbp-related predominantly upper-limb distal myopathy | Enrichment | TARDBP | 1.60 |
| 323 | Wfs1 spectrum disorder | Enrichment | WFS1 | 1.60 |
| 324 | Inherited creutzfeldt-jakob disease | Enrichment | PRNP | 1.60 |
| 325 | Gastrointestinal system disease | Enrichment | RET | 1.60 |
| 326 | Parkinsonism due to atp13a2 deficiency | Enrichment | ATP13A2 | 1.60 |
| 327 | Hereditary arginine vasopressin deficiency | Enrichment | AVP | 1.60 |
| 328 | Multiple endocrine neoplasia | Enrichment | RET | 1.60 |
| 329 | Movement disease | Enrichment | GNAO1, SCN2A | 1.53 |
| 330 | Presynaptic congenital myasthenic syndromes | Enrichment | SNAP25, VAMP1 | 1.53 |
| 331 | Cardiac conduction defect | Enrichment | SCN1B, SCN5A | 1.45 |
| 332 | Epicanthus | Enrichment | KCNQ2, TFAP2A | 1.45 |
| 333 | Juvenile myelomonocytic leukemia | Enrichment | ARHGAP26, NF1 | 1.45 |
| 334 | Long qt syndrome 1 | Enrichment | CALM1, SCN10A, SCN5A | 1.41 |
| 335 | Pheochromocytoma | Enrichment | NF1, RET | 1.33 |
| 336 | Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | Enrichment | PARK7 | 1.30 |
| 337 | Spinocerebellar ataxia 29 | Enrichment | ITPR1 | 1.30 |
| 338 | Seizures, benign familial neonatal, 1 | Enrichment | KCNQ2 | 1.30 |
| 339 | Spinocerebellar ataxia 1 | Enrichment | ATXN1 | 1.30 |
| 340 | Cafe-au-lait spots, multiple | Enrichment | NF1 | 1.30 |
| 341 | Atrial standstill 1 | Enrichment | SCN5A | 1.30 |
| 342 | Progressive familial heart block, type ia | Enrichment | SCN5A | 1.30 |
| 343 | Spastic ataxia 1, autosomal dominant | Enrichment | VAMP1 | 1.30 |
| 344 | Paramyotonia congenita | Enrichment | SCN4A | 1.30 |
| 345 | Seizures, benign familial neonatal, 2 | Enrichment | KCNQ2 | 1.30 |
| 346 | Major affective disorder 1 | Enrichment | TPH2 | 1.30 |
| 347 | Hyperekplexia 1 | Enrichment | GPHN | 1.30 |
| 348 | Scoliosis, isolated 1 | Enrichment | MAPK7 | 1.30 |
| 349 | Insensitivity to pain, congenital, with anhidrosis | Enrichment | NTRK1 | 1.30 |
| 350 | Alexander disease | Enrichment | GFAP | 1.30 |
| 351 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 1.30 |
| 352 | Batten-turner congenital myopathy | Enrichment | SCN4A | 1.30 |
| 353 | Cutis marmorata telangiectatica congenita | Enrichment | GNA11 | 1.30 |
| 354 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 | Enrichment | TREM2 | 1.30 |
| 355 | Indifference to pain, congenital, autosomal recessive | Enrichment | SCN9A | 1.30 |
| 356 | Encephalopathy, neonatal severe, due to mecp2 mutations | Enrichment | MECP2 | 1.30 |
| 357 | Fg syndrome 4 | Enrichment | CASK | 1.30 |
| 358 | Parkinson disease 12 | Enrichment | PRKN | 1.30 |
| 359 | Intellectual developmental disorder with autism and speech delay | Enrichment | TBR1 | 1.30 |
| 360 | Alzheimer disease 9 | Enrichment | SORL1 | 1.30 |
| 361 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 1.30 |
| 362 | Parkinson disease 8, autosomal dominant | Enrichment | LRRK2 | 1.30 |
| 363 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | PRKAR1A | 1.30 |
| 364 | Sick sinus syndrome 1 | Enrichment | SCN5A | 1.30 |
| 365 | Schwannomatosis 1 | Enrichment | NF2 | 1.30 |
| 366 | Myotonia, potassium-aggravated | Enrichment | SCN4A | 1.30 |
| 367 | Hereditary motor and sensory neuropathy, type iic | Enrichment | NEFH | 1.30 |
| 368 | Intellectual developmental disorder, autosomal recessive 5 | Enrichment | SYNGAP1 | 1.30 |
| 369 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 1.30 |
| 370 | Segawa syndrome, autosomal recessive | Enrichment | TH | 1.30 |
| 371 | Keppen-lubinsky syndrome | Enrichment | KCNJ6 | 1.30 |
| 372 | Lissencephaly 1 | Enrichment | PAFAH1B1 | 1.30 |
| 373 | Creutzfeldt-jakob disease | Enrichment | PRNP | 1.30 |
| 374 | Orofacial cleft 5 | Enrichment | MSX1 | 1.30 |
| 375 | Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads | Enrichment | CAST | 1.30 |
| 376 | Adams-oliver syndrome 5 | Enrichment | NOTCH1 | 1.30 |
| 377 | Amyotrophic lateral sclerosis 16, juvenile | Enrichment | SIGMAR1 | 1.30 |
| 378 | Epilepsy, early-onset, 5, with or without developmental delay | Enrichment | CNTN2 | 1.30 |
| 379 | Orthostatic hypotension 1 | Enrichment | DBH | 1.30 |
| 380 | Myoclonic epilepsy, familial infantile | Enrichment | CPLX1 | 1.30 |
| 381 | Neuronopathy, distal hereditary motor, autosomal recessive 2 | Enrichment | SIGMAR1 | 1.30 |
| 382 | Developmental and epileptic encephalopathy 34 | Enrichment | SLC12A5 | 1.30 |
| 383 | Retinal dystrophy, juvenile cataracts, and short stature syndrome | Enrichment | GPHN | 1.30 |
| 384 | Atrial fibrillation, familial, 10 | Enrichment | SCN5A | 1.30 |
| 385 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 1.30 |
| 386 | Witkop syndrome | Enrichment | MSX1 | 1.30 |
| 387 | Aromatic l-amino acid decarboxylase deficiency | Enrichment | DDC | 1.30 |
| 388 | Migraine, familial hemiplegic, 3 | Enrichment | SCN1A | 1.30 |
| 389 | Pitt-hopkins-like syndrome 1 | Enrichment | CNTNAP2 | 1.30 |
| 390 | Spastic paraplegia 76, autosomal recessive | Enrichment | CAPN1 | 1.30 |
| 391 | Palmoplantar keratoderma, nonepidermolytic, focal 1 | Enrichment | TRPV3 | 1.30 |
| 392 | Cognitive impairment with or without cerebellar ataxia | Enrichment | SCN8A | 1.30 |
| 393 | Spastic paraplegia, intellectual disability, nystagmus, and obesity | Enrichment | GFAP | 1.30 |
| 394 | Long qt syndrome 14 | Enrichment | CALM1 | 1.30 |
| 395 | Hypothyroidism, congenital, nongoitrous, 6 | Enrichment | NR1D1 | 1.30 |
| 396 | Oguchi disease 2 | Enrichment | SAG | 1.30 |
| 397 | Spastic paraplegia 79b, autosomal recessive | Enrichment | UCHL1 | 1.30 |
| 398 | Abdominal obesity-metabolic syndrome 3 | Enrichment | DYRK1B | 1.30 |
| 399 | Pain sensitivity quantitative trait locus 1 | Enrichment | NTRK1 | 1.30 |
| 400 | Long qt syndrome 3 | Enrichment | SCN5A | 1.30 |
| 401 | Developmental and epileptic encephalopathy 6b | Enrichment | SCN1A | 1.30 |
| 402 | Charcot-marie-tooth disease, demyelinating, type 4d | Enrichment | NDRG1 | 1.30 |
| 403 | Bartter syndrome, type 1, antenatal | Enrichment | SLC12A1 | 1.30 |
| 404 | Sinoatrial node disease | Enrichment | SCN5A | 1.30 |
| 405 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 1.30 |
| 406 | Spastic tetraplegia, thin corpus callosum, and progressive microcephaly | Enrichment | SLC1A4 | 1.30 |
| 407 | Intellectual developmental disorder, x-linked 90 | Enrichment | DLG3 | 1.30 |
| 408 | Neuropathy, congenital hypomyelinating, 2 | Enrichment | RHO | 1.30 |
| 409 | Developmental dysplasia of the hip 3 | Enrichment | LRP1 | 1.30 |
| 410 | Microcephaly 21, primary, autosomal recessive | Enrichment | GAPDH | 1.30 |
| 411 | Congenital myopathy 22a, classic | Enrichment | SCN4A | 1.30 |
| 412 | Hypophosphatemia | Enrichment | NHERF1 | 1.30 |
| 413 | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures | Enrichment | AGTPBP1 | 1.30 |
| 414 | Nephrotic syndrome, type 17 | Enrichment | GGA3 | 1.30 |
| 415 | Congenital myopathy 22b, severe fetal | Enrichment | SCN4A | 1.30 |
| 416 | Chromosome 17q11.2 duplication syndrome, 1.4-mb | Enrichment | NF1 | 1.30 |
| 417 | Usher syndrome, type iv | Enrichment | PRKAR1A | 1.30 |
| 418 | Hyperlipoproteinemia, type iii | Enrichment | APOE | 1.30 |
| 419 | Infantile myofibromatosis | Enrichment | NOTCH3 | 1.30 |
| 420 | Intellectual developmental disorder, x-linked, syndromic 13 | Enrichment | MECP2 | 1.30 |
| 421 | Perrault syndrome 3 | Enrichment | CLPP | 1.30 |
| 422 | Myasthenic syndrome, congenital, 16 | Enrichment | SCN4A | 1.30 |
| 423 | Osteopetrosis, autosomal recessive 3 | Enrichment | CA2 | 1.30 |
| 424 | Kala-azar 2 | Enrichment | GSTP1 | 1.30 |
| 425 | Bilateral generalized polymicrogyria | Enrichment | GRIN1 | 1.30 |
| 426 | Molybdenum cofactor deficiency, type c | Enrichment | GPHN | 1.30 |
| 427 | Intellectual developmental disorder, autosomal dominant 21 | Enrichment | GRIN2A | 1.30 |
| 428 | Hereditary spastic paraplegia 79a | Enrichment | UCHL1 | 1.30 |
| 429 | Autosomal dominant hypocalcemia | Enrichment | GNA11 | 1.30 |
| 430 | Syndromic x-linked intellectual disability | Enrichment | CASK | 1.30 |
| 431 | Dopamine beta-hydroxylase deficiency | Enrichment | DBH | 1.30 |
| 432 | X-linked intellectual disability-psychosis-macroorchidism syndrome | Enrichment | MECP2 | 1.30 |
| 433 | Central precocious puberty | Enrichment | KISS1R | 1.30 |
| 434 | Lipodystrophy, familial partial, type 1 | Enrichment | NOTCH3 | 1.30 |
| 435 | Developmental and epileptic encephalopathy 96 | Enrichment | NSF | 1.30 |
| 436 | Optic disk drusen | Enrichment | RHO | 1.30 |
| 437 | Renal tubular acidosis | Enrichment | SLC4A1 | 1.30 |
| 438 | Vulto-van silfhout-de vries syndrome | Enrichment | DLG4 | 1.30 |
| 439 | Acrodysostosis | Enrichment | PRKAR1A | 1.30 |
| 440 | Benign familial neonatal epilepsy | Enrichment | SCN2A | 1.30 |
| 441 | Depressive disorder | Enrichment | NOTCH3 | 1.30 |
| 442 | Congenital mesoblastic nephroma | Enrichment | NTRK3 | 1.30 |
| 443 | Developmental and epileptic encephalopathy 30 | Enrichment | SCN2A | 1.30 |
| 444 | Phelan-mcdermid syndrome | Enrichment | SHANK3 | 1.30 |
| 445 | Neurodegeneration, childhood-onset, with cerebellar atrophy | Enrichment | AGTPBP1 | 1.30 |
| 446 | Medullary thyroid carcinoma | Enrichment | RET | 1.30 |
| 447 | Fibrolamellar carcinoma | Enrichment | PRKACA | 1.30 |
| 448 | Wolfram syndrome | Enrichment | WFS1 | 1.30 |
| 449 | Psychotic disorder | Enrichment | SHANK3 | 1.30 |
| 450 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 1.30 |
| 451 | Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction | Enrichment | NKX2-1 | 1.30 |
| 452 | Cortical dysplasia, complex, with other brain malformations 1 | Enrichment | TUBB3 | 1.30 |
| 453 | Spastic paraplegia 79a, autosomal dominant, with ataxia | Enrichment | UCHL1 | 1.30 |
| 454 | Ichthyosis, congenital, autosomal recessive 10 | Enrichment | KCNQ2 | 1.30 |
| 455 | Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia | Enrichment | OPTN | 1.30 |
| 456 | Bardet-biedl syndrome 9 | Enrichment | NF1 | 1.30 |
| 457 | Spastic tetraplegia and axial hypotonia, progressive | Enrichment | SOD1 | 1.30 |
| 458 | Megalencephaly-polydactyly syndrome | Enrichment | MYCN | 1.30 |
| 459 | Fibrosarcoma | Enrichment | NTRK3 | 1.30 |
| 460 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 1.30 |
| 461 | Renal tubular acidosis, distal, 4, with hemolytic anemia | Enrichment | SLC4A1 | 1.30 |
| 462 | Hypokalemic periodic paralysis, type 2 | Enrichment | SCN4A | 1.30 |
| 463 | Spastic ataxia 1 | Enrichment | VAMP1 | 1.30 |
| 464 | Amyotrophic lateral sclerosis type 12 | Enrichment | OPTN | 1.30 |
| 465 | Scn1a seizure disorders | Enrichment | SCN1A | 1.30 |
| 466 | Seizures, benign familial infantile, 5 | Enrichment | SCN8A | 1.30 |
| 467 | Immunodeficiency 57 with autoinflammation | Enrichment | RIPK1 | 1.30 |
| 468 | Esotropia | Enrichment | TFAP2A | 1.30 |
| 469 | Myasthenic syndrome, congenital, 25, presynaptic | Enrichment | VAMP1 | 1.30 |
| 470 | 9q33.3q34.11 microdeletion syndrome | Enrichment | STXBP1 | 1.30 |
| 471 | Mitochondrial dna depletion syndrome 15 | Enrichment | TFAM | 1.30 |
| 472 | Multiple benign circumferential skin creases on limbs | Enrichment | TUBB | 1.30 |
| 473 | Charcot-marie-tooth disease type 4d | Enrichment | NDRG1 | 1.30 |
| 474 | Malignant migrating partial seizures of infancy | Enrichment | SCN2A | 1.30 |
| 475 | Developmental and epileptic encephalopathy 76 | Enrichment | SCN1A | 1.30 |
| 476 | Distal hereditary motor neuropathy type 7 | Enrichment | DCTN1 | 1.30 |
| 477 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 1.30 |
| 478 | Rolandic epilepsy-speech dyspraxia syndrome | Enrichment | GRIN2A | 1.30 |
| 479 | Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | Enrichment | SLC1A4 | 1.30 |
| 480 | Small fiber neuropathy | Enrichment | SCN9A | 1.30 |
| 481 | Self-limited neonatal epilepsy | Enrichment | KCNQ2 | 1.30 |
| 482 | Benign neonatal seizures | Enrichment | SCN2A | 1.30 |
| 483 | Isolated atrial standstill | Enrichment | SCN5A | 1.30 |
| 484 | Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion | Enrichment | TBR1 | 1.30 |
| 485 | Oguchi disease | Enrichment | SAG | 1.30 |
| 486 | Familial retinoblastoma | Enrichment | MYCN | 1.30 |
| 487 | Dominant hypophosphatemia with nephrolithiasis or osteoporosis | Enrichment | NHERF1 | 1.30 |
| 488 | Lens subluxation | Enrichment | TFAP2A | 1.30 |
| 489 | Familial patent arterial duct | Enrichment | TFAP2B | 1.30 |
| 490 | Pleomorphic rhabdomyosarcoma | Enrichment | NF1 | 1.30 |
| 491 | Progressive bulbar palsy | Enrichment | MECP2 | 1.30 |
| 492 | Nkx2-1-related disorders | Enrichment | NKX2-1 | 1.30 |
| 493 | Epilepsy-aphasia spectrum | Enrichment | GRIN2A | 1.30 |
| 494 | Submucosal cleft palate | Enrichment | UBB | 1.30 |
| 495 | Cleft hard palate | Enrichment | UBB | 1.30 |
| 496 | Bruxism | Enrichment | MECP2 | 1.30 |
| 497 | Familial hypercholesterolemia | Enrichment | APOE, PCSK9 | 1.27 |
| 498 | Schizophrenia | Enrichment | COMT, DLG2, PRKN, SYN2 | 1.22 |
| 499 | Hypertension, essential | Enrichment | AGT, GNB3 | 1.17 |
| 500 | Sudden infant death syndrome | Enrichment | SCN1A, SCN5A | 1.17 |
| 501 | Laryngomalacia | Enrichment | MECP2 | 1.13 |
| 502 | Dystonia 12 | Enrichment | SCN2A | 1.13 |
| 503 | Dystonia, dopa-responsive | Enrichment | TH | 1.13 |
| 504 | Retinoblastoma | Enrichment | MYCN | 1.13 |
| 505 | Klippel-feil syndrome 1, autosomal dominant | Enrichment | LRRK2 | 1.13 |
| 506 | Myopia 2, autosomal dominant | Enrichment | CNP | 1.13 |
| 507 | Thrombocythemia 1 | Enrichment | CALR | 1.13 |
| 508 | Gillespie syndrome | Enrichment | ITPR1 | 1.13 |
| 509 | Uvula, bifid | Enrichment | UBB | 1.13 |
| 510 | Intellectual developmental disorder, x-linked 96 | Enrichment | SYP | 1.13 |
| 511 | Watson syndrome | Enrichment | NF1 | 1.13 |
| 512 | Niemann-pick disease, type a | Enrichment | APBB1 | 1.13 |
| 513 | Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia | Enrichment | CASK | 1.13 |
| 514 | Heart defects, congenital, and other congenital anomalies | Enrichment | DLG4 | 1.13 |
| 515 | Obesity, early-onset, with adrenal insufficiency and red hair | Enrichment | POMC | 1.13 |
| 516 | Cleft soft palate | Enrichment | UBB | 1.13 |
| 517 | Niemann-pick disease, type b | Enrichment | APBB1 | 1.13 |
| 518 | Leber congenital amaurosis 13 | Enrichment | GPHN | 1.13 |
| 519 | Intellectual developmental disorder, autosomal dominant 5 | Enrichment | SYNGAP1 | 1.13 |
| 520 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | GNA11 | 1.13 |
| 521 | Glaucoma, normal tension | Enrichment | OPTN | 1.13 |
| 522 | Neurofibromatosis, familial spinal | Enrichment | NF1 | 1.13 |
| 523 | Generalized epilepsy with febrile seizures plus, type 2 | Enrichment | SCN1A | 1.13 |
| 524 | Developmental and epileptic encephalopathy 13 | Enrichment | SCN8A | 1.13 |
| 525 | Chromosome 17q11.2 deletion syndrome, 1.4-mb | Enrichment | NF1 | 1.13 |
| 526 | Miller-dieker lissencephaly syndrome | Enrichment | PAFAH1B1 | 1.13 |
| 527 | Generalized epilepsy with febrile seizures plus, type 7 | Enrichment | SCN9A | 1.13 |
| 528 | Chromosome 17p13.3, centromeric, duplication syndrome | Enrichment | PAFAH1B1 | 1.13 |
| 529 | Tremor, hereditary essential, 6 | Enrichment | SCN4A | 1.13 |
| 530 | Glycosylphosphatidylinositol biosynthesis defect 17 | Enrichment | GPHN | 1.13 |
| 531 | Keratosis follicularis spinulosa decalvans | Enrichment | LRP1 | 1.13 |
| 532 | Intellectual developmental disorder, autosomal dominant 62 | Enrichment | DLG4 | 1.13 |
| 533 | Torsion dystonia 1 | Enrichment | TOR1A | 1.13 |
| 534 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | Enrichment | TRPV3 | 1.13 |
| 535 | Neurodevelopmental disorder with hypotonia and impaired expressive language and with or without seizures | Enrichment | DLG4 | 1.13 |
| 536 | Syndromic x-linked intellectual disability najm type | Enrichment | CASK | 1.13 |
| 537 | Precocious puberty, central, 2 | Enrichment | KISS1R | 1.13 |
| 538 | Cerebellar disease | Enrichment | CASK | 1.13 |
| 539 | Gingival overgrowth | Enrichment | RET | 1.13 |
| 540 | Cellular ependymoma | Enrichment | NF2 | 1.13 |
| 541 | Tanycytic ependymoma | Enrichment | NF2 | 1.13 |
| 542 | Papillary ependymoma | Enrichment | NF2 | 1.13 |
| 543 | Migraine without aura | Enrichment | NOTCH3 | 1.13 |
| 544 | Microcephaly 17, primary, autosomal recessive | Enrichment | RHO | 1.13 |
| 545 | Brain cancer | Enrichment | NF1 | 1.13 |
| 546 | Dlg4-related synaptopathy | Enrichment | DLG4 | 1.13 |
| 547 | Arachnoid cyst | Enrichment | GPHN | 1.13 |
| 548 | Advanced sleep phase syndrome | Enrichment | CSNK1D | 1.13 |
| 549 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.13 |
| 550 | Tubulinopathy-associated dysgyria | Enrichment | TUBB3 | 1.13 |
| 551 | Melanoma of soft tissue | Enrichment | CREB1 | 1.13 |
| 552 | Spindle cell sarcoma | Enrichment | NF2 | 1.13 |
| 553 | Clear cell ependymoma | Enrichment | NF2 | 1.13 |
| 554 | Hypomyelination neuropathy-arthrogryposis syndrome | Enrichment | CNTNAP1 | 1.13 |
| 555 | Hereditary episodic ataxia | Enrichment | SCN2A | 1.13 |
| 556 | Obesity due to pro-opiomelanocortin deficiency | Enrichment | POMC | 1.13 |
| 557 | Parkinson's disease | Enrichment | LRRK2, PRKN | 1.09 |
| 558 | Charcot-marie-tooth disease | Enrichment | DCTN1, NDRG1, NEFL | 1.08 |
| 559 | Type 2 diabetes mellitus | Enrichment | NEUROD1, PTPN1, WFS1 | 1.05 |
| 560 | Craniosynostosis | Enrichment | GRIN2B, TFAP2B | 1.05 |
| 561 | Chorea, benign hereditary | Enrichment | NKX2-1 | 1.01 |
| 562 | Branchiooculofacial syndrome | Enrichment | TFAP2A | 1.01 |
| 563 | Huntington disease | Enrichment | HTT | 1.01 |
| 564 | Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema | Enrichment | SLC4A1 | 1.01 |
| 565 | Acyl-coa dehydrogenase, very long-chain, deficiency of | Enrichment | DLG4 | 1.01 |
| 566 | Fucosidosis | Enrichment | DCX | 1.01 |
| 567 | Neuropathy, hereditary sensory and autonomic, type iia | Enrichment | SCN9A | 1.01 |
| 568 | Myopathy, centronuclear, 2 | Enrichment | BIN1 | 1.01 |
| 569 | Thyroid cancer, nonmedullary, 1 | Enrichment | NKX2-1 | 1.01 |
| 570 | Astigmatism | Enrichment | GRIN2B | 1.01 |
| 571 | Macular degeneration, age-related, 1 | Enrichment | APOE | 1.01 |
| 572 | Budd-chiari syndrome | Enrichment | CALR | 1.01 |
| 573 | Developmental and epileptic encephalopathy 2 | Enrichment | SNAP25 | 1.01 |
| 574 | Neurofibromatosis-noonan syndrome | Enrichment | NF1 | 1.01 |
| 575 | Ventricular fibrillation, paroxysmal familial, 1 | Enrichment | SCN5A | 1.01 |
| 576 | Frontotemporal dementia 2 | Enrichment | PRNP | 1.01 |
| 577 | Fragile x tremor/ataxia syndrome | Enrichment | FMR1 | 1.01 |
| 578 | Developmental and epileptic encephalopathy 4 | Enrichment | STXBP1 | 1.01 |
| 579 | Carney complex variant | Enrichment | PRKAR1A | 1.01 |
| 580 | Spinocerebellar ataxia 15 | Enrichment | ITPR1 | 1.01 |
| 581 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.01 |
| 582 | Long qt syndrome 2 | Enrichment | SCN5A | 1.01 |
| 583 | Hyperkalemic periodic paralysis | Enrichment | SCN4A | 1.01 |
| 584 | Developmental and epileptic encephalopathy 12 | Enrichment | SCN2A | 1.01 |
| 585 | Tobacco addiction | Enrichment | GABBR2 | 1.01 |
| 586 | Central hypoventilation syndrome, congenital, 1 | Enrichment | RET | 1.01 |
| 587 | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities | Enrichment | GAD1 | 1.01 |
| 588 | Intellectual developmental disorder with speech delay, autism, and dysmorphic facies | Enrichment | TBR1 | 1.01 |
| 589 | Macular dystrophy with or without cone dysfunction | Enrichment | GPHN | 1.01 |
| 590 | Hereditary sensory and autonomic neuropathy type 2 | Enrichment | SCN9A | 1.01 |
| 591 | Developmental and epileptic encephalopathy 52 | Enrichment | SCN1B | 1.01 |
| 592 | Enophthalmos | Enrichment | DYRK1A | 1.01 |
| 593 | Fragile x-associated tremor/ataxia syndrome | Enrichment | FMR1 | 1.01 |
| 594 | Atrial fibrillation | Enrichment | SCN5A | 1.01 |
| 595 | Dowling-degos disease | Enrichment | PSENEN | 1.01 |
| 596 | Hereditary ataxia | Enrichment | NKX2-1 | 1.01 |
| 597 | Cerebrovascular disease | Enrichment | NOTCH3 | 1.01 |
| 598 | Embryonal rhabdomyosarcoma | Enrichment | NF1 | 1.01 |
| 599 | Sotos syndrome 1 | Enrichment | SCN4A | 1.01 |
| 600 | Pilocytic astrocytoma | Enrichment | NF1 | 1.01 |
| 601 | Spastic quadriplegic cerebral palsy | Enrichment | GAD1 | 1.01 |
| 602 | Oligohydramnios | Enrichment | OPHN1 | 1.01 |
| 603 | Idiopathic achalasia | Enrichment | NOS1 | 1.01 |
| 604 | Diabetes insipidus | Enrichment | AVP | 1.01 |
| 605 | Episodic ataxia | Enrichment | SCN2A | 1.01 |
| 606 | Familial or sporadic hemiplegic migraine | Enrichment | SCN1A | 1.01 |
| 607 | Hermansky-pudlak syndrome due to bloc-1 deficiency | Enrichment | DTNBP1 | 1.01 |
| 608 | Full schwannomatosis | Enrichment | NF2 | 1.01 |
| 609 | Genetic central precocious puberty in male | Enrichment | KISS1R | 1.01 |
| 610 | Glioma | Enrichment | NTRK3 | 1.01 |
| 611 | Haddad syndrome | Enrichment | RET | 1.01 |
| 612 | Benign ependymoma | Enrichment | NF2 | 1.01 |
| 613 | Middle aortic syndrome | Enrichment | NF1 | 1.01 |
| 614 | Cleft lip and alveolus | Enrichment | MSX1 | 1.01 |
| 615 | Paroxysmal familial ventricular fibrillation | Enrichment | SCN5A | 1.01 |
| 616 | Familial sick sinus syndrome | Enrichment | SCN5A | 1.01 |
| 617 | Pseudomyogenic hemangioendothelioma | Enrichment | FOSB | 1.01 |
| 618 | Attention deficit-hyperactivity disorder | Enrichment | MECP2, TBR1 | 0.98 |
| 619 | Microphthalmia | Enrichment | DYRK1A, TFAP2A | 0.98 |
| 620 | Skin disease | Enrichment | NCSTN, NF1 | 0.98 |
| 621 | Malaria | Enrichment | SCN8A, SLC4A1 | 0.95 |
| 622 | Sensorineural hearing loss | Enrichment | NEFL, RET, SLC12A2 | 0.92 |
| 623 | Alzheimer disease 2 | Enrichment | APOE | 0.92 |
| 624 | Sotos syndrome | Enrichment | SCN4A | 0.92 |
| 625 | Feingold syndrome 1 | Enrichment | MYCN | 0.92 |
| 626 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | Enrichment | NOTCH3 | 0.92 |
| 627 | Retinal detachment | Enrichment | RHO | 0.92 |
| 628 | Multiple endocrine neoplasia, type iia | Enrichment | RET | 0.92 |
| 629 | Niemann-pick disease, type c1 | Enrichment | APBB1 | 0.92 |
| 630 | Anemia, congenital, nonspherocytic hemolytic, 1 | Enrichment | CASK | 0.92 |
| 631 | Premature ovarian failure 1 | Enrichment | FMR1 | 0.92 |
| 632 | Fragile x syndrome | Enrichment | FMR1 | 0.92 |
| 633 | Parkinson disease 2, autosomal recessive juvenile | Enrichment | PRKN | 0.92 |
| 634 | Rhabdomyosarcoma 2 | Enrichment | NF1 | 0.92 |
| 635 | Convulsions, familial infantile, with paroxysmal choreoathetosis | Enrichment | SCN8A | 0.92 |
| 636 | Major depressive disorder | Enrichment | TPH2 | 0.92 |
| 637 | Narcolepsy 2 | Enrichment | HCRT | 0.92 |
| 638 | Charcot-marie-tooth disease, axonal, type 2e | Enrichment | NEFL | 0.92 |
| 639 | Chromosome 15q11.2 deletion syndrome | Enrichment | PAFAH1B1 | 0.92 |
| 640 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | L1CAM | 0.92 |
| 641 | Heart conduction disease | Enrichment | SCN5A | 0.92 |
| 642 | Amblyopia | Enrichment | TFAP2A | 0.92 |
| 643 | Cardiac arrest | Enrichment | SCN5A | 0.92 |
| 644 | Hyperekplexia | Enrichment | GPHN | 0.92 |
| 645 | Osteopetrosis | Enrichment | CA2 | 0.92 |
| 646 | Niemann-pick disease | Enrichment | APBB1 | 0.92 |
| 647 | Night blindness | Enrichment | RHO | 0.92 |
| 648 | Histiocytoid hemangioma | Enrichment | FOSB | 0.92 |
| 649 | Parkin type of early-onset parkinson disease | Enrichment | PRKN | 0.92 |
| 650 | Vascular dementia | Enrichment | NOTCH3 | 0.92 |
| 651 | Cleft upper lip | Enrichment | MSX1 | 0.92 |
| 652 | Genetic motor neuron disease | Enrichment | DCTN1 | 0.92 |
| 653 | Sensory peripheral neuropathy | Enrichment | SCN11A | 0.92 |
| 654 | Sleep disorder | Enrichment | GRIN2B | 0.92 |
| 655 | Scoliosis | Enrichment | GFAP, GRIN2B | 0.92 |
| 656 | Tetralogy of fallot | Enrichment | NOTCH1, RET | 0.86 |
| 657 | Rasopathy | Enrichment | DDC, NF1 | 0.86 |
| 658 | Auditory neuropathy | Enrichment | NEFL, NOTCH3 | 0.86 |
| 659 | Angelman syndrome | Enrichment | MECP2 | 0.85 |
| 660 | Glaucoma, primary open angle | Enrichment | OPTN | 0.85 |
| 661 | Klippel-trenaunay-weber syndrome | Enrichment | GNAQ | 0.85 |
| 662 | Hypokalemic periodic paralysis, type 1 | Enrichment | SCN4A | 0.85 |
| 663 | Dystonia 11, myoclonic | Enrichment | TOR1A | 0.85 |
| 664 | Branchiootorenal syndrome 1 | Enrichment | TFAP2A | 0.85 |
| 665 | Myopathy, centronuclear, 1 | Enrichment | BIN1 | 0.85 |
| 666 | Machado-joseph disease | Enrichment | LRRK2 | 0.85 |
| 667 | Renal tubular acidosis, distal, 1 | Enrichment | SLC4A1 | 0.85 |
| 668 | Wolf-hirschhorn syndrome | Enrichment | CPLX1 | 0.85 |
| 669 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | PSEN1 | 0.85 |
| 670 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | GLUD1 | 0.85 |
| 671 | Metachromatic leukodystrophy | Enrichment | GFAP | 0.85 |
| 672 | Renal tubular dysgenesis | Enrichment | AGT | 0.85 |
| 673 | Anxiety | Enrichment | GPHN | 0.85 |
| 674 | Congenital anomalies of kidney and urinary tract 1 | Enrichment | TRAP1 | 0.85 |
| 675 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | RIPK1 | 0.85 |
| 676 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 0.85 |
| 677 | Spinocerebellar ataxia, autosomal recessive 16 | Enrichment | ITPR1 | 0.85 |
| 678 | Pontocerebellar hypoplasia, type 1e | Enrichment | AGTPBP1 | 0.85 |
| 679 | Familial adult myoclonic epilepsy | Enrichment | CNTN2 | 0.85 |
| 680 | Intestinal pseudo-obstruction | Enrichment | TFAP2B | 0.85 |
| 681 | Congenital fibrosis of the extraocular muscles | Enrichment | TUBB3 | 0.85 |
| 682 | Pain disorder | Enrichment | SCN4A | 0.85 |
| 683 | Lipid metabolism disorder | Enrichment | APOE | 0.85 |
| 684 | Adrenocortical carcinoma | Enrichment | PRKAR1A | 0.85 |
| 685 | Early myoclonic encephalopathy | Enrichment | KCND2 | 0.85 |
| 686 | Hereditary spherocytosis | Enrichment | SLC4A1 | 0.85 |
| 687 | Il10-related early-onset inflammatory bowel disease | Enrichment | RIPK1 | 0.85 |
| 688 | Autosomal recessive distal renal tubular acidosis | Enrichment | SLC4A1 | 0.85 |
| 689 | Distal renal tubular acidosis | Enrichment | SLC4A1 | 0.85 |
| 690 | Nonsyndromic genetic hyperinsulinism | Enrichment | GLUD1 | 0.85 |
| 691 | Sporadic pheochromocytoma/secreting paraganglioma | Enrichment | RET | 0.85 |
| 692 | Familial isolated dilated cardiomyopathy | Enrichment | PSEN1, PSEN2, SCN5A | 0.83 |
| 693 | Fundus albipunctatus | Enrichment | RHO | 0.79 |
| 694 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-1 | 0.79 |
| 695 | Myelofibrosis | Enrichment | CALR | 0.79 |
| 696 | Coats disease | Enrichment | RHO | 0.79 |
| 697 | Polymicrogyria, bilateral perisylvian, x-linked | Enrichment | WFS1 | 0.79 |
| 698 | Adams-oliver syndrome | Enrichment | NOTCH1 | 0.79 |
| 699 | Alzheimer's disease 1 | Enrichment | APP | 0.79 |
| 700 | Branchiootorenal syndrome | Enrichment | TFAP2A | 0.79 |
| 701 | Essential thrombocythemia | Enrichment | CALR | 0.79 |
| 702 | Bartter disease | Enrichment | SLC12A1 | 0.79 |
| 703 | Pilomyxoid astrocytoma | Enrichment | NTRK2 | 0.79 |
| 704 | Long qt syndrome | Enrichment | CALM1, SCN5A | 0.74 |
| 705 | Arthrogryposis, distal, type 1a | Enrichment | CNTNAP1 | 0.73 |
| 706 | Narcolepsy 1 | Enrichment | HCRT | 0.73 |
| 707 | Renal hypodysplasia/aplasia 1 | Enrichment | RET | 0.73 |
| 708 | Ewing sarcoma | Enrichment | NF1 | 0.73 |
| 709 | Lennox-gastaut syndrome | Enrichment | SCN1A | 0.73 |
| 710 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 0.73 |
| 711 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1 | 0.73 |
| 712 | Hypothyroidism | Enrichment | RET | 0.73 |
| 713 | Neuroblastoma | Enrichment | MYCN | 0.73 |
| 714 | Homozygous familial hypercholesterolemia | Enrichment | PCSK9 | 0.73 |
| 715 | Hypoplastic left heart syndrome | Enrichment | NOTCH1 | 0.73 |
| 716 | Male infertility due to globozoospermia | Enrichment | PICK1 | 0.73 |
| 717 | Early-onset posterior polar cataract | Enrichment | PANK4 | 0.73 |
| 718 | Peripheral nervous system disease | Enrichment | NEFL, NGF | 0.72 |
| 719 | Neuropathy | Enrichment | NEFL, NGF | 0.72 |
| 720 | Tooth agenesis, selective, 1 | Enrichment | MSX1 | 0.69 |
| 721 | Ellis-van creveld syndrome | Enrichment | PRKACA | 0.69 |
| 722 | Leukemia, acute lymphoblastic 3 | Enrichment | NF1 | 0.69 |
| 723 | Perrault syndrome 2 | Enrichment | CLPP | 0.69 |
| 724 | Bilateral perisylvian polymicrogyria | Enrichment | WFS1 | 0.69 |
| 725 | Hypogonadotropic hypogonadism | Enrichment | KISS1R | 0.69 |
| 726 | Congenital central hypoventilation syndrome | Enrichment | RET | 0.69 |
| 727 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | SCN5A | 0.69 |
| 728 | Juvenile amyotrophic lateral sclerosis | Enrichment | SIGMAR1 | 0.69 |
| 729 | Hydrops fetalis | Enrichment | L1CAM | 0.69 |
| 730 | Renal agenesis, bilateral | Enrichment | RET | 0.69 |
| 731 | Cat eye syndrome | Enrichment | TFAP2A | 0.65 |
| 732 | Leukemia, chronic lymphocytic | Enrichment | P2RX7 | 0.65 |
| 733 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Enrichment | TARDBP | 0.65 |
| 734 | Stroke, ischemic | Enrichment | NOTCH3 | 0.65 |
| 735 | Neurodegeneration with brain iron accumulation | Enrichment | ATP13A2 | 0.65 |
| 736 | Nephrocalcinosis | Enrichment | SLC12A1 | 0.65 |
| 737 | Autosomal non-syndromic agammaglobulinemia | Enrichment | LRRC8A | 0.65 |
| 738 | Migraine with or without aura 1 | Enrichment | NOTCH3 | 0.61 |
| 739 | Immune deficiency disease | Enrichment | RIPK1 | 0.61 |
| 740 | Meningioma, familial | Enrichment | NF2 | 0.61 |
| 741 | Diabetes mellitus | Enrichment | WFS1 | 0.61 |
| 742 | Systemic lupus erythematosus | Enrichment | ITGAM, MECP2 | 0.59 |
| 743 | Cerebral palsy | Enrichment | GPHN, GRIN2B | 0.59 |
| 744 | Digeorge syndrome | Enrichment | COMT | 0.58 |
| 745 | Renal hypodysplasia/aplasia 3 | Enrichment | RET | 0.58 |
| 746 | Meningioma | Enrichment | NF2 | 0.58 |
| 747 | Congenital long qt syndrome | Enrichment | SCN5A | 0.58 |
| 748 | Postsynaptic congenital myasthenic syndromes | Enrichment | SCN4A | 0.58 |
| 749 | Aortic valve disease 1 | Enrichment | NOTCH1 | 0.55 |
| 750 | Hypercholesterolemia, familial, 1 | Enrichment | PCSK9 | 0.55 |
| 751 | Acute promyelocytic leukemia | Enrichment | PRKAR1A | 0.55 |
| 752 | Multiple sclerosis | Enrichment | ITPR1 | 0.52 |
| 753 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | KISS1R | 0.52 |
| 754 | Aortic aneurysm, familial thoracic 1 | Enrichment | NOTCH1 | 0.52 |
| 755 | Lung cancer susceptibility 3 | Enrichment | PRKN | 0.52 |
| 756 | Cataract | Enrichment | RHO | 0.52 |
| 757 | Congenital myasthenic syndrome | Enrichment | VAMP1 | 0.52 |
| 758 | Cleft lip/palate | Enrichment | MSX1 | 0.52 |
| 759 | Pituitary stalk interruption syndrome | Enrichment | KISS1R | 0.52 |
| 760 | Optic atrophy plus syndrome | Enrichment | SNAP25, WFS1 | 0.52 |
| 761 | Anterior segment dysgenesis | Enrichment | ITPR1 | 0.50 |
| 762 | Hermansky-pudlak syndrome | Enrichment | DTNBP1 | 0.50 |
| 763 | Rare genetic intellectual disability | Enrichment | GNAO1 | 0.50 |
| 764 | Male infertility with spermatogenesis disorder | Enrichment | DYRK1A | 0.50 |
| 765 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | CASK | 0.48 |
| 766 | Hermansky-pudlak syndrome 1 | Enrichment | DTNBP1 | 0.48 |
| 767 | Wolff-parkinson-white syndrome | Enrichment | SCN5A | 0.48 |
| 768 | Hydrocephalus, congenital, 1 | Enrichment | TUBB | 0.48 |
| 769 | Perrault syndrome 1 | Enrichment | CLPP | 0.48 |
| 770 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | SCN5A | 0.48 |
| 771 | Rhabdomyosarcoma | Enrichment | NF1 | 0.48 |
| 772 | Isolated congenital microcephaly | Enrichment | CASK | 0.48 |
| 773 | Cardiomyopathy, dilated, 1e | Enrichment | SCN5A | 0.45 |
| 774 | Syndromic intellectual disability | Enrichment | SYT1 | 0.45 |
| 775 | Charcot-marie-tooth disease type 4 | Enrichment | NDRG1 | 0.43 |
| 776 | Normosmic congenital hypogonadotropic hypogonadism | Enrichment | KISS1R | 0.43 |
| 777 | Early-onset nuclear cataract | Enrichment | WFS1 | 0.43 |
| 778 | Hypertelorism | Enrichment | RET, TFAP2A | 0.42 |
| 779 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | TNC, WFS1 | 0.42 |
| 780 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | NEFL | 0.42 |
| 781 | Congenital myopathy | Enrichment | SCN4A | 0.42 |
| 782 | Williams-beuren syndrome | Enrichment | STX1A | 0.40 |
| 783 | Maturity-onset diabetes of the young | Enrichment | NEUROD1 | 0.40 |
| 784 | Focal segmental glomerulosclerosis | Enrichment | TRPC6 | 0.40 |
| 785 | Hereditary breast ovarian cancer syndrome | Enrichment | NF1, RIPK1 | 0.39 |
| 786 | Myeloma, multiple | Enrichment | NF1, NKX2-1 | 0.38 |
| 787 | Inherited cancer-predisposing syndrome | Enrichment | NF1, NF2, PRKAR1A, RET | 0.37 |
| 788 | Hepatocellular carcinoma | Enrichment | RET | 0.37 |
| 789 | Tooth agenesis | Enrichment | MSX1 | 0.37 |
| 790 | Autosomal recessive non-syndromic intellectual disability | Enrichment | GRIA1, GRIN1 | 0.37 |
| 791 | Primary ovarian insufficiency | Enrichment | NOTCH2, NTRK1 | 0.36 |
| 792 | Cone dystrophy | Enrichment | SAG | 0.34 |
| 793 | Ovarian cancer | Enrichment | NTRK1, PRKN, RET | 0.33 |
| 794 | Jeune thoracic dystrophy | Enrichment | GRK2 | 0.33 |
| 795 | Strabismus | Enrichment | STXBP1 | 0.30 |
| 796 | Asphyxiating thoracic dystrophy | Enrichment | GRK2 | 0.29 |
| 797 | Cone-rod dystrophy 2 | Enrichment | GPHN, RHO | 0.29 |
| 798 | Bladder cancer | Enrichment | NF1 | 0.28 |
| 799 | Hirschsprung disease 1 | Enrichment | RET | 0.28 |
| 800 | Prostate cancer | Enrichment | EPHB2 | 0.28 |
| 801 | Stargardt disease 1 | Enrichment | GPHN | 0.27 |
| 802 | Lung cancer | Enrichment | PRKN | 0.25 |
| 803 | Cystic fibrosis | Enrichment | STX1A | 0.25 |
| 804 | Connective tissue disease | Enrichment | NOTCH1 | 0.25 |
| 805 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | GRK2 | 0.25 |
| 806 | Cakut | Enrichment | TRAP1 | 0.24 |
| 807 | Genetic steroid-resistant nephrotic syndrome | Enrichment | TRPC6 | 0.24 |
| 808 | Left ventricular noncompaction | Enrichment | SCN5A | 0.23 |
| 809 | Eye disease | Enrichment | GPHN | 0.23 |
| 810 | Non-syndromic genetic deafness | Enrichment | WFS1 | 0.22 |
| 811 | Myopathy | Enrichment | SCN4A | 0.19 |
| 812 | Bardet-biedl syndrome | Enrichment | COMT | 0.18 |
| 813 | Nonsyndromic hearing loss | Enrichment | WFS1 | 0.18 |
| 814 | Gastric cancer | Enrichment | NF1 | 0.18 |
| 815 | Nephrotic syndrome | Enrichment | TRPC6 | 0.18 |
| 816 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | NOTCH1 | 0.17 |
| 817 | Hereditary breast carcinoma | Enrichment | RET | 0.17 |
| 818 | Breast cancer | Enrichment | RET | 0.07 |
| 819 | Primary ciliary dyskinesia | Enrichment | PRKAR1B | 0.07 |
| 820 | Hereditary retinal dystrophy | Enrichment | GPHN, NEUROD1, RHO, SAG, WFS1 | 0.07 |
| 821 | Fundus dystrophy | Enrichment | GPHN, NEUROD1, RHO, SAG, WFS1 | 0.07 |
| 822 | Rare genetic deafness | Enrichment | WFS1 | 0.06 |
| 823 | Dilated cardiomyopathy | Enrichment | SCN5A | 0.06 |
| 824 | Colorectal cancer | Enrichment | RET | 0.05 |
| 825 | Retinitis pigmentosa | Enrichment | GPHN, RHO, SAG | 0.04 |
| 826 | Leber plus disease | Enrichment | GPHN | 0.04 |